Allo-cel

N/A

Report date: 2023/07/28 18:04:14

First In Class

Base Information

Drug NameAllo-cel

Drug Alias NameAllo-cel

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiosyngen Pte Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A